Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study-0

<p><b>Copyright information:</b></p><p>Taken from "Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study"</p><p>BMC Infectious Diseases 2004;4():50-50.</p><p>Published online 17 Nov 2004</p><p>PMCID:PMC534101.</p><p>Copyright © 2004 Van Weyenbergh et al; licensee BioMed Central Ltd.</p>endemic (E) controls; and patients with mucosal leishmaniasis (ML), localized cutaneous leishmaniasis before (LCL0) and after 3 months of treatment (LCL3), and visceral leishmaniasis (VL). *p < 0.05, **p < 0.01, ***p < .001 for LCL0 and ML . E and for VL . U (Mann-Whitney test)